Ovarian Cancer: An Integrated Review

To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term survivorship concerns. This article will also examine current and future clinical trials surrounding ovarian cancer. A review of articles dated 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in oncology nursing Jg. 35; H. 2; S. 151 - 156
Hauptverfasser: Stewart, Christine, Ralyea, Christine, Lockwood, Suzy
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.04.2019
Schlagworte:
BRCA
Female
gynecologic
Humans
oncology
ovarian cancer
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - epidemiology
Ovarian Neoplasms - prevention & control
Ovarian Neoplasms - therapy
prevention
Risk Factors
gynecologic
BRCA
risk factors
ovarian cancer
oncology
prevention
ISSN:0749-2081, 1878-3449, 1878-3449
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term survivorship concerns. This article will also examine current and future clinical trials surrounding ovarian cancer. A review of articles dated 2006–2018 from CINAHL, UpToDate, and National Comprehensive Cancer Network guidelines. There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in this population. Early identification can range from knowing the vague symptoms associated with the cancer to prophylactic surgical removal of at-risk tissue. Standard treatment for ovarian cancer is surgery followed by combination chemotherapy. Although advances are being made, ovarian cancer remains the most fatal female gynecologic cancer. Becoming familiar with and educating women about risk factors and the elusive symptoms of ovarian cancer can increase patient autonomy and advocacy, as well as potentially improve patient outcomes for those affected by ovarian cancer.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0749-2081
1878-3449
1878-3449
DOI:10.1016/j.soncn.2019.02.001